|
C19ORF70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.916900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.570900E-04 |
| Normal-vs-Stage2 |
8.895800E-01 |
| Normal-vs-Stage3 |
7.844600E-01 |
| Normal-vs-Stage4 |
1.503640E-01 |
| Stage1-vs-Stage2 |
2.619000E-03 |
| Stage1-vs-Stage3 |
8.382400E-03 |
| Stage1-vs-Stage4 |
8.759800E-01 |
| Stage2-vs-Stage3 |
7.262200E-01 |
| Stage2-vs-Stage4 |
1.435440E-01 |
| Stage3-vs-Stage4 |
1.007980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.799300E-03 |
| Normal-vs-AfricanAmerican |
8.343600E-02 |
| Normal-vs-Asian |
5.369600E-01 |
| Caucasian-vs-AfricanAmerican |
7.851000E-01 |
| Caucasian-vs-Asian |
8.806400E-01 |
| AfricanAmerican-vs-Asian |
8.303200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.600700E-03 |
| Normal-vs-Female |
7.384100E-02 |
| Male-vs-Female |
9.551400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.148400E-02 |
| Normal-vs-Extreme_Weight |
7.441100E-04 |
| Normal-vs-Obese |
1.996420E-01 |
| Normal-vs-Extreme_Obese |
7.387900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.456400E-01 |
| Normal_Weight-vs-Obese |
2.963800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.265200E-01 |
| Extreme_Weight-vs-Obese |
4.818300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.325400E-01 |
| Obese-vs-Extreme_Obese |
7.053600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.209600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.804000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.156900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.771600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.029980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.790600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.890160E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.640000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.731980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.348000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.009400E-04 |
| Normal-VS-Type2 PRCC |
6.360200E-01 |
| Normal-VS-KIRP CIMP |
7.130600E-01 |
| Normal-VS-Unclassified PRCC |
2.757800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.258900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.203000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.287200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.900800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.285400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.421600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.629980E-02 |
| Normal-vs-N1 |
1.351160E-01 |
| Normal-vs-N2 |
2.606800E-01 |
| N0-vs-N1 |
5.184000E-04 |
| N0-vs-N2 |
9.942400E-01 |
| N1-vs-N2 |
8.494500E-02 |
|
|
